HEADER ANTIMICROBIAL, ANTITUMOR PROTEIN 24-NOV-14 2MWT TITLE NMR STRUCTURE OF CROTALICIDIN IN DPC MICELLES COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHELICIDIN-LIKE PEPTIDE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 161-194; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: CROTALUS DURISSUS TERRIFICUS; SOURCE 4 ORGANISM_COMMON: SOUTH AMERICAN RATTLESNAKE,CASCABEL; SOURCE 5 ORGANISM_TAXID: 8732 KEYWDS ANTIMICROBIAL PEPTIDE, ANTITUMOR PEPTIDE, ANTIMICROBIAL PROTEIN, KEYWDS 2 ANTITUMOR PROTEIN, ANTIMICROBIAL EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR M.JIMENEZ,H.ZAMORA-CARRERAS REVDAT 3 14-JUN-23 2MWT 1 REMARK REVDAT 2 09-DEC-15 2MWT 1 JRNL REVDAT 1 04-NOV-15 2MWT 0 JRNL AUTH C.B.FALCAO,C.PEREZ-PEINADO,B.G.DE LA TORRE,X.MAYOL, JRNL AUTH 2 H.ZAMORA-CARRERAS,M.A.JIMENEZ,G.RADIS-BAPTISTA,D.ANDREU JRNL TITL STRUCTURAL DISSECTION OF CROTALICIDIN, A RATTLESNAKE VENOM JRNL TITL 2 CATHELICIDIN, RETRIEVES A FRAGMENT WITH ANTIMICROBIAL AND JRNL TITL 3 ANTITUMOR ACTIVITY. JRNL REF J.MED.CHEM. V. 58 8553 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26465972 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01142 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SPARKY, CYANA REMARK 3 AUTHORS : GODDARD (SPARKY), GUNTERT, MUMENTHALER AND REMARK 3 WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MWT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-NOV-14. REMARK 100 THE DEPOSITION ID IS D_1000104142. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 308 REMARK 210 PH : 3.0; 3.0 REMARK 210 IONIC STRENGTH : 0; 0 REMARK 210 PRESSURE : AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM CROTALICIDIN, 30 MM [U-98% REMARK 210 2H] DPC, 0.1 MM DSS, 90% H2O/10% REMARK 210 D2O; 1 MM CROTALICIDIN, 30 MM [U- REMARK 210 98% 2H] DPC, 0.1 MM DSS, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H COSY; 2D 1H-1H TOCSY; REMARK 210 2D 1H-1H NOESY; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 2D 1H-13C HSQC REMARK 210 AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY, TOPSPIN, TALOS, CYANA REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PHE A 22 38.93 -99.30 REMARK 500 2 PHE A 22 39.66 -97.31 REMARK 500 2 MET A 26 -70.68 -67.16 REMARK 500 2 VAL A 27 145.94 -171.91 REMARK 500 4 PHE A 22 31.09 -98.00 REMARK 500 4 PRO A 33 99.48 -69.78 REMARK 500 5 PHE A 22 40.09 -98.87 REMARK 500 5 PRO A 25 99.14 -69.69 REMARK 500 5 PRO A 33 81.84 -69.73 REMARK 500 6 PRO A 33 90.30 -69.82 REMARK 500 8 PRO A 33 95.87 -69.72 REMARK 500 9 MET A 26 -73.96 -71.85 REMARK 500 9 VAL A 27 136.62 -175.64 REMARK 500 10 PHE A 22 38.25 -97.05 REMARK 500 12 PRO A 25 94.96 -69.72 REMARK 500 12 MET A 26 -74.53 -118.28 REMARK 500 13 PHE A 22 40.11 -100.04 REMARK 500 13 PRO A 25 84.05 -69.69 REMARK 500 14 MET A 26 -73.81 -81.75 REMARK 500 14 PRO A 33 95.57 -69.82 REMARK 500 16 PHE A 22 40.03 -99.63 REMARK 500 17 PHE A 22 35.90 -98.97 REMARK 500 18 PHE A 22 40.05 -100.70 REMARK 500 19 PHE A 22 36.53 -99.79 REMARK 500 19 VAL A 27 142.79 -173.08 REMARK 500 20 PRO A 25 84.16 -69.77 REMARK 500 20 MET A 26 -71.42 -65.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25363 RELATED DB: BMRB DBREF 2MWT A 1 34 UNP U5KJM4 U5KJM4_CRODU 161 194 SEQRES 1 A 34 LYS ARG PHE LYS LYS PHE PHE LYS LYS VAL LYS LYS SER SEQRES 2 A 34 VAL LYS LYS ARG LEU LYS LYS ILE PHE LYS LYS PRO MET SEQRES 3 A 34 VAL ILE GLY VAL THR ILE PRO PHE HELIX 1 1 ARG A 2 PHE A 22 1 21 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1